Summary
Machine-generated summaryAmgros has issued a prior information notice about its planned tender for the purchase of infusion and injection solutions containing carbohydrates (ATC code B05BA03) and electrolytes (ATC code B05BB01). The purpose of the notice is to give general information about the coming procurement and to open a market dialogue. The choice of tender procedure and the resulting timetable have not yet been decided, but Amgros expects to publish the tender notice in the first quarter of 2027. Any dates given are indicative only and the schedule may change. The information in the notice is preliminary and non-binding, and Amgros reserves the right to change or stop the process without prior warning.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 5 days ago
The buyer
Full buyer profileAmgros I/S
- notices in the register
- 535
- awards
- 270
Who wins its contracts
Many suppliers- different companies won its awards
- 178
- of the awards went to the three most frequent winners
- 6%
- of its calls state an estimated value
- 97%
Based on 222 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.4
- of those lots received a single tender
- 34%
- of the awards went to companies based in another country
- 20%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Roche Pharmaceuticals A/S | 5 | May 2026 | |
| Abacus Medicine A/S | 4 | Sep 2026 | |
| AstraZeneca A/S | 4 | Sep 2026 | |
| Gilead Sciences Denmark ApS | 4 | May 2026 | |
| Janssen-Cilag A/S | 4 | Apr 2026 |
Based on 219 awards with a linked company profile over the last 5 years.
10 open tenders right now
- Medicines - Amgros 2027 1.1076.a 2 days left
- Pharmaceuticals - Amgros 2027 1.1212.a 6 days left
- Pharmaceuticals - Amgros 2027 1.486.a 6 days left
Market context
- open now in Medical equipment & pharmaceuticals
- 8,432
- median open notice
- €253,808
Who wins in this market
Many suppliersDenmark · Medical equipment & pharmaceuticals
- different companies won awards here
- 312
- of the awards went to the three most frequent winners
- 5%
- buyers awarded contracts here
- 73
Based on 400 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 28%
- of the awards went to companies based in another country
- 15%
- of the tenders came from another country
- 23%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
Awarded before
Never miss a tender like this
7 new notices in Medical equipment & pharmaceuticals in Denmark in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.